Back to Medicines

Cobicistat: What a Booster Does to Your Other Medicines

Cobicistat: What a Booster Does to Your Other Medicines
Prescription Medicines Editorial 4 January 2026

Cobicistat is a pharmacokinetic booster. Unlike ritonavir, from which it was derived, it has no antiviral activity at all - its only function is to inhibit CYP3A4, the liver enzyme that clears a large share of prescribed medicines, so that the drug given alongside it stays at useful levels for longer. That means every effect cobicistat has on you is an effect on something else you are taking.

Follow the plan your prescriber gave you. This guide contains no doses.

Where it is used

Cobicistat boosts protease inhibitors such as darunavir and atazanavir, and the integrase inhibitor elvitegravir. It appears inside several single-tablet HIV regimens, where its presence is easy to overlook because the combination is known by one name.

See darunavir, the drug it most often accompanies.

Compared with ritonavir

Both inhibit CYP3A4 strongly, and the interaction profiles are broadly similar.

The differences are that cobicistat is more selective - it affects fewer other enzyme systems - has no antiviral activity, and tends to cause less gastrointestinal upset and fewer effects on lipids. It also has a specific effect on creatinine, described below.

Neither is inherently better. Which is used depends on the regimen and on your other medicines.

The creatinine rise

Cobicistat blocks a transporter that moves creatinine from the blood into the urine. That raises the measured creatinine level, and lowers the calculated eGFR, without any change in actual kidney function.

The rise appears within the first weeks and then plateaus. It is expected and benign.

The practical problem is that a GP or hospital doctor seeing that result out of context may conclude kidney function has deteriorated and change or stop a medicine unnecessarily.

If anyone raises your kidney results, mention that you take cobicistat. A continuing rise, rather than a stable one, is different and does need investigating - see medicines that affect your kidneys.

The interactions that cause real harm

Inhaled and nasal steroids. Fluticasone is normally cleared so efficiently by the liver that very little reaches the circulation. Block the enzyme and levels rise steeply, producing Cushing's syndrome and adrenal suppression from what looks like an ordinary preventer inhaler or hay fever spray. See steroid inhaler safety.

Statins. Levels rise, raising the risk of severe muscle breakdown. Simvastatin is contraindicated; others are capped or substituted - see statins and muscle pain.

Sedatives such as midazolam, where prolonged sedation and respiratory depression can result.

Ergot medicines for migraine, which can cause severe blood vessel narrowing.

Some heart rhythm drugs and anticoagulants - see apixaban.

Erectile dysfunction medicines, where levels can rise severalfold - see sildenafil.

Some sedating antihistamines, antipsychotics and immunosuppressants including tacrolimus and ciclosporin - see tacrolimus.

And the ones that stop it working

Enzyme inducers reduce both cobicistat and whatever it is boosting, risking treatment failure and resistance.

Rifampicin is contraindicated. So is St John's wort, which is sold freely over the counter. Carbamazepine, phenytoin and phenobarbital all reduce levels substantially.

See carbamazepine and supplements that interfere with your medicines.

What this means in practice

Every new medicine needs checking against your regimen - every time, including anything bought over the counter, herbal or recreational.

The difficulty specific to cobicistat is that it is invisible. It sits inside a combination tablet with a brand name, and neither you nor a new prescriber necessarily connects that name to a powerful enzyme inhibitor.

Carry a list of your medicines by ingredient rather than by brand, and say explicitly that your regimen contains a booster. See over-the-counter interactions.

Free HIV interaction checkers are available online, and your specialist pharmacist will check anything for you.

Side effects of its own

Few, since it has no pharmacological target beyond the enzyme. Nausea and diarrhoea occur, generally less than with ritonavir.

Jaundice and raised liver enzymes are reported - report jaundice, dark urine or persistent abdominal pain.

Do not stop it separately

Because the booster has no antiviral effect of its own, people occasionally reason that stopping it alone is harmless. It is not.

Removing the booster causes the drug it supports to fall to ineffective levels within a day, which is functionally the same as stopping treatment - and the falling levels are precisely the conditions that generate resistance. The two are taken together or not at all.

In hepatitis C treatment

Cobicistat also appears in some hepatitis C regimens, where the same interaction rules apply exactly. If you are prescribed one, the medication review beforehand is the substantive part of the assessment, not a formality.

If this was useful, Bictegravir: A Single-Tablet HIV Regimen is worth reading next, and Medicines collects the rest.